Company Information

    Pneuma Respiratory was founded on January 2015. The company is based in Boone, NC, USA . The number of employees in Pneuma Respiratory is less than 10. Pneuma respiratory is a pharmaceutical company that creates digital solutions for respiratory drug delivery.

    Here is how Pneuma Respiratory describes itself: "A Revolution in Drug Delivery Delivering advanced aerosol technology to improve global human health APPLICATIONS THE FIRST DIGITAL, BREATH-ACTUATED INHALER Pneuma is a biopharmaceutical company with advanced aerosol technology that creates breakthrough pulmonary drug delivery solutions. Pneuma’s world class capabilities, partnerships and bold vision create new approaches that dramatically improve the existing standard of care […]"
      If you are the founder or part of the founding team, please tell the world your story

          Funding & investors

          Pneuma Respiratory has received 3 rounds of venture funding. The total funding amount is around $23.3M.

            Similar Companies [beta]

              Venture Categories

                Active Venture Investors

                  Venture Competitors


                        Pneuma Respiratory - Blog

                          • Pneuma Respiratory and Leads Biolabs, Inc. Announce Partnership

                          • Pneuma Respiratory, Inc., developer of a proprietary breath-activated digital inhaler (BDI), and Leads Biolabs Inc. announce an agreement granting Pneuma an exclusive license to develop Leads Biolabs’ panel of immuno-oncology monoclonal antibodies and fusion protein molecules for the pulmonary delivery of Leads’ antibodies and molecules.  Using Pneuma’s digital inhaler platform, the agreement provides access to the untapped […]
                          • Pneuma Respiratory, Inc. Announces J. Knox Singleton Joins the Board of Directors

                          • BOONE, N.C., Oct. 26, 2018 /PRNewswire/ — Pneuma Respiratory, Inc., which has developed PNEUMAHALER™, the first breath-activated digital inhaler (BDI), announced its Board of Directors has elected shareholder J. Knox Singleton to the Board. Until his retirement in July 2018, Mr. Singleton, served for 35 years as the CEO of Inova Health System, the largest employer in Northern Virginia, […]
                          • Haisco Pharmaceutical Group Co Ltd to Make a $10 Million Equity Investment in Pneuma Respiratory and Enters into a Distribution Agreement

                          • BOONE, N.C., Aug. 13, 2018 /PRNewswire/ — Pneuma Respiratory, Inc., which has developed PNEUMAHALER™,, the first breath-activated digital inhaler (BDI), announced that Haisco Pharmaceutical Group Co Ltd, a China-based company focused on the research and development and marketing of therapeutic drugs, has agreed to make a $10 million equity investment in Pneuma Respiratory.  As part of the agreement, Haisco Pharmaceutical Group […]
                          • Pharmaceutical Company Pneuma Respiratory Raises $8.3 Million Series A

                          • BOONE, N.C., July 18, 2018 /PRNewswire/ — Pneuma Respiratory, Inc., which has developed PNEUMAHALER™,, the first breath-activated digital inhaler (BDI), has raised $8.3 million in a Series A financing round. Pneuma Respiratory, Inc. (“Pneuma”) has developed the PNEUMAHALER™ Breath Activated Digital Inhaler (BDI) to solve the problems of existing metered dose, dry- powder, and soft-mist inhalers to improve the efficacy of […]
                          • Pneuma Respiratory Appoints Rich Gimigliano as Chief Financial Officer

                          • BOONE, North Carolina., April 16, 2018/PRNewswire/– Pneuma Respiratory, Inc. (Pneuma), which has developed PNEUMAHALERTM, the first fully digital breath activated inhaler (DBI), has hired Rich Gimigliano as Chief Financial Officer. Rich Gimigliano brings over thirty years of Wall Street experience across a wide variety of investment banking and capital markets roles to Pneuma. He has […]
                          • Pneuma Respiratory Develops Digital Soft Mist Inhaler Device

                          • US-based pharmaceutical firm Pneuma Respiratory has developed a fully digital, soft mist inhaler device designed to deliver a variety of medicines to the lungs. The inhaler uses electronic breath actuation and a soft mist ejector, which can sense the breath and automatically activate upon inhalation by a patient. The need for a propellant is eliminated […]

                          Share:     facebook    twitter    linkedin    reddit    email

                            Ventures Media is one of the largest startup and venture capital communities for startup and venture capital funding information and analysis.

                            Leave a Reply

                            Your email address will not be published. Required fields are marked *